Literature DB >> 1953237

Ribavirin therapy of adult respiratory syncytial virus pneumonitis.

R B Aylward1, D R Burdge.   

Abstract

Respiratory syncytial virus is a common respiratory tract pathogen in infants. Pulmonary infection in adult and elderly populations can occur with severe and even fatal pneumonitis having been reported in several recent outbreaks. We present a previously healthy adult patient who developed respiratory syncytial virus pneumonia severe enough to require mechanical ventilation. Antiviral therapy with aerosolized ribavirin was successfully undertaken and the patient recovered completely. Respiratory syncytial virus infection should be considered in the differential diagnosis of atypical adult pneumonias. Aerosolized ribavirin therapy may be beneficial in treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953237

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  RFI-641, a potent respiratory syncytial virus inhibitor.

Authors:  Clayton C Huntley; William J Weiss; Anna Gazumyan; Aron Buklan; Boris Feld; William Hu; Thomas R Jones; Timothy Murphy; Antonia A Nikitenko; Bryan O'Hara; Gregory Prince; Susan Quartuccio; Yuri E Raifeld; Philip Wyde; John F O'Connell
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 2.  Respiratory syncytial virus infection in the elderly.

Authors:  G Mlinaric-Galinovic; A R Falsey; E E Walsh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

Review 3.  Medical treatment of viral pneumonia including SARS in immunocompetent adult.

Authors:  V C C Cheng; B S F Tang; A K L Wu; C M Chu; K Y Yuen
Journal:  J Infect       Date:  2004-11       Impact factor: 6.072

Review 4.  Respiratory syncytial virus.

Authors:  O Ruuskanen; P L Ogra
Journal:  Curr Probl Pediatr       Date:  1993-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.